Bristol Myers Squibb Co. (BMY)
57.48
-0.63
(-1.08%)
USD |
NYSE |
Mar 20, 16:00
57.64
+0.16
(+0.28%)
After-Hours: 20:00
Bristol Myers Squibb Research and Development Expense (Quarterly) : 2.561B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 2.151B |
| Gilead Sciences, Inc. | 1.565B |
| Johnson & Johnson | 4.268B |
| Janux Therapeutics, Inc. | 31.55M |
| Moderna, Inc. | 708.00M |